FLNA FILANA THERAPEUTICS, INC.
Healthcare · Pharmaceutical Preparations · Market cap: $21.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $3.0M | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $2.3M | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $831.4K | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $253.9K |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $591.0K | $0 |
| 2025-Q4 | $640.7K | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $356.3K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$7.8M19 buy days
Sold$253.9K2 sell days
Net insider flow+$7.5Mnet buying · 5 years
Latest trade2026-09-30Barry Richard
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Buy | Barry Richard | CEO | 100,000 | $0.92 | $92.0K | 1 |
| 2026-09-29 | Buy | Barry Richard | CEO | 206,813 | $0.90 | $186.1K | 1 |
| 2026-09-28 | Buy | Barry Richard | CEO | 93,091 | $0.84 | $78.2K | 1 |
| 2025-11-24 | Buy | Anderson Robert Eugene Jr | Director | 8,600 | $2.90 | $24.9K | 1 |
| 2025-11-20 | Buy | Barry Richard | CEO | 150,000 | $2.76 | $414.0K | 1 |
| 2025-11-19 | Buy | Barry Richard | CEO | 73,385 | $2.75 | $201.8K | 1 |
| 2025-09-30 | Buy | Cook Robert Christopher | COO | 13,725 | $2.91 | $39.9K | 1 |
| 2025-09-22 | Buy | Barry Richard | CEO | 7,172 | $2.28 | $16.4K | 1 |
| 2025-09-19 | Buy | Barry Richard | CEO | 47,308 | $2.29 | $108.3K | 2 |
| 2025-09-18 | Buy | Barry Richard | CEO | 190,633 | $2.24 | $426.4K | 2 |
| 2024-11-29 | Sell | Schoen Eric | CFO | 61,800 | $3.86 | $238.5K | 2 |
| 2024-11-29 | Sell | Kupiec James William | Other C-suite | 4,000 | $3.87 | $15.5K | 1 |
| 2023-08-23 | Buy | ROBERTSON SANFORD | Director | 30,000 | $17.45 | $523.5K | 1 |
| 2023-08-22 | Buy | Barry Richard | Director | 16,571 | $16.65 | $275.9K | 1 |
| 2023-08-21 | Buy | Barry Richard | Director | 1,906 | $16.80 | $32.0K | 1 |
| 2023-03-07 | Buy | Barry Richard | Director | 77,276 | $25.76 | $2.0M | 1 |
| 2023-03-06 | Buy | Barry Richard | Director | 11,565 | $26.13 | $302.2K | 1 |
| 2022-08-23 | Buy | Barry Richard | Director | 36,159 | $23.79 | $860.2K | 1 |
| 2022-08-23 | Buy | Kupiec James William | Other C-suite | 2,500 | $24.44 | $61.1K | 1 |
| 2022-08-12 | Buy | ROBERTSON SANFORD | Director | 100,000 | $20.69 | $2.1M | 1 |
| 2022-08-12 | Buy | Schoen Eric | CFO | 2,500 | $19.95 | $49.9K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Barry Richard | CEO | $5.0M | $0 | 2026-09-30 |
| ROBERTSON SANFORD | Director | $2.6M | $0 | 2023-08-23 |
| Schoen Eric | CFO | $49.9K | $238.5K | 2024-11-29 |
| Kupiec James William | Other C-suite | $61.1K | $15.5K | 2024-11-29 |
| Cook Robert Christopher | COO | $39.9K | $0 | 2025-09-30 |
| Anderson Robert Eugene Jr | Director | $24.9K | $0 | 2025-11-24 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-08-12 → 2022-08-23 | 4 | $3.0M | 58 | +73.2% (+58.6% raw) | +21.8% (+18.0% raw) | -11.3% (-13.1% raw) | closed |
| 2020-09-17 → 2020-09-24 | 3 | $2.0M | 62 | -20.9% (-9.7% raw) | -64.9% (-25.7% raw) | +285.1% (+337.8% raw) | closed |
| 2019-12-18 → 2019-12-31 | 3 | $1.7M | 60 | +94.7% (+92.8% raw) | +24.9% (-6.0% raw) | -13.0% (-27.9% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.